| Sep 5 |
Gilead to Present New Trodelvy® Data at the IASLC 2024 World Conference on Lung Cancer
|
| Sep 4 |
Gilead Sciences: Innovative Approaches to Healthcare Can Remove Barriers
|
| Sep 4 |
Avenzo and Gilead partner for breast cancer combination regimen trial
|
| Sep 3 |
Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street
|
| Sep 3 |
Gilead Sciences Options Trading: A Deep Dive into Market Sentiment
|
| Sep 2 |
Gilead Sciences Might Finally Be On Its Way To Higher Stock Prices
|
| Sep 2 |
Gilead Sciences, Inc. (NASDAQ:GILD) is favoured by institutional owners who hold 86% of the company
|
| Aug 30 |
Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.
|
| Aug 30 |
Gilead Sciences: Buy This Bargain Before It's Gone
|
| Aug 30 |
How Gilead Sciences, Virtus Investment And Hess Midstream Could Put Cash In Your Pocket
|
